Arthur C. Butcher - 21 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP& Grp Pres, MedSurg & APAC
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 21 Feb 2023
Net transactions value: -$35,181
Form type: 4
Filing time: 22 Feb 2023, 15:54:00 UTC
Previous filing: 21 Feb 2023
Next filing: 24 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+1,714	+6%	$0.000000	30,445	21 Feb 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	$35,181	-761	-2.5%	$46.23	29,684	21 Feb 2023	Direct
holding	BSX	Common Stock						2,545	21 Feb 2023	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1,714	-100%	$0.000000^*	0	21 Feb 2023	Common Stock	1,714		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.